Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos-Reference-Cited by-同舟云学术

Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos

Published:2017-09 Issue:9 Volume:53 Page:501-509
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:es
Short-container-title:Archivos de Bronconeumología

Author:

Caminero José A.,Cayla Joan A.,García-García José-María,García-Pérez Francisco J.,Palacios Juan J.,Ruiz-Manzano Juan

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference61 articles.

1. World Health Organization. Global tuberculosis report 2016. World Health Organization Document. 2016;WHO/HTM/TB/2016.13:1-194.

2. Tuberculosis: Are we making it incurable? (Editorial);Caminero;Eur Respir J,2013

3. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization Document. 2006;WHO/HTM/TB/2006.361:1-174.

4. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008. World Health Organization Document. 2008;WHO/HTM/TB/2008.402:1-247.

5. World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization Document. 2014;WHO/HTM/TB/2014.11:1-403.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Tuberculosis Treatment: Uncovering New Drugs and Breakthrough Inhibitors to Combat Drug-Resistant Mycobacterium tuberculosis;ACS Infectious Diseases;2023-11-09

2. Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems;Antibiotics;2022-06-15

3. Differences in the Structure and Antimicrobial Activity of Hydrazones Derived from Methyl 4-Phenylpicolinimidate;Materials;2022-04-24

4. [Translated article] Drug Resistant Tuberculosis: New WHO Definitions and Their Implication in the SEPAR Guideline;Archivos de Bronconeumología;2022-01

5. Tuberculosis con resistencia a fármacos: nuevas definiciones de la OMS y su implicación en la Normativa de SEPAR;Archivos de Bronconeumología;2022-01